FI87790C - Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt - Google Patents

Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt Download PDF

Info

Publication number
FI87790C
FI87790C FI883596A FI883596A FI87790C FI 87790 C FI87790 C FI 87790C FI 883596 A FI883596 A FI 883596A FI 883596 A FI883596 A FI 883596A FI 87790 C FI87790 C FI 87790C
Authority
FI
Finland
Prior art keywords
formula
compound
alkyl
cycloalkyl
substituted
Prior art date
Application number
FI883596A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI883596A7 (fi
FI883596A0 (fi
FI87790B (fi
Inventor
John F Kadow
Mark G Saulnier
Peter D Senter
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI883596A0 publication Critical patent/FI883596A0/fi
Publication of FI883596A7 publication Critical patent/FI883596A7/fi
Application granted granted Critical
Publication of FI87790B publication Critical patent/FI87790B/fi
Publication of FI87790C publication Critical patent/FI87790C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
FI883596A 1987-08-04 1988-08-01 Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt FI87790C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US8149387 1987-08-04
US19973188 1988-05-27
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (4)

Publication Number Publication Date
FI883596A0 FI883596A0 (fi) 1988-08-01
FI883596A7 FI883596A7 (fi) 1989-02-05
FI87790B FI87790B (fi) 1992-11-13
FI87790C true FI87790C (fi) 1993-02-25

Family

ID=26765636

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883596A FI87790C (fi) 1987-08-04 1988-08-01 Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt

Country Status (34)

Country Link
US (3) US4904768A (OSRAM)
JP (1) JPH0699465B2 (OSRAM)
KR (1) KR900006230B1 (OSRAM)
CN (1) CN1027169C (OSRAM)
AT (1) AT398974B (OSRAM)
BE (1) BE1002982A4 (OSRAM)
CA (1) CA1310637C (OSRAM)
CH (1) CH676716A5 (OSRAM)
CY (1) CY1625A (OSRAM)
CZ (1) CZ286893B6 (OSRAM)
DD (2) DD299067A5 (OSRAM)
DE (1) DE3826562A1 (OSRAM)
DK (2) DK169344B1 (OSRAM)
ES (1) ES2010775A6 (OSRAM)
FI (1) FI87790C (OSRAM)
FR (1) FR2622193B1 (OSRAM)
GB (1) GB2207674B (OSRAM)
GR (1) GR1000490B (OSRAM)
HK (1) HK6392A (OSRAM)
HU (3) HU202547B (OSRAM)
IE (1) IE61040B1 (OSRAM)
IL (1) IL87290A (OSRAM)
IT (1) IT1226825B (OSRAM)
LU (2) LU87290A1 (OSRAM)
MX (1) MX173843B (OSRAM)
MY (1) MY104321A (OSRAM)
NL (2) NL192683C (OSRAM)
NO (4) NO170284C (OSRAM)
NZ (1) NZ225615A (OSRAM)
PT (1) PT88186B (OSRAM)
SE (1) SE502214C2 (OSRAM)
SG (1) SG101291G (OSRAM)
SK (1) SK541288A3 (OSRAM)
YU (3) YU143688A (OSRAM)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (OSRAM) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
CA2085520C (en) * 1991-12-23 1996-07-16 Uday Shankar Gogate Stable hexahydrate of etoposide 4'-phosphate disodium salt
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
US5942386A (en) * 1995-06-07 1999-08-24 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
JP2000507577A (ja) 1996-04-01 2000-06-20 エピックス メディカル，インコーポレイテッド 画像診断用の生物活性造影剤
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
AP2003002831A0 (en) * 2001-10-26 2003-09-30 Centre Nat Rech Scient Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
EP2283868B1 (en) 2002-07-15 2016-03-30 Board of Regents, The University of Texas System Peptides binding to phosphatidylethanolamine and their use in treating viral infections and cancer
WO2004060403A2 (en) * 2003-01-06 2004-07-22 Angiochem Inc. Aprotinin and anglos as carriers across the blood-brain barrier
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
EP1859041B2 (en) * 2005-02-18 2014-11-19 Angiochem Inc. Aprotinin polypeptides for transporting a compound across the blood-brain barrier
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
ES2744225T3 (es) * 2005-07-15 2020-02-24 Angiochem Inc Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009036106A1 (en) * 2007-09-13 2009-03-19 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
DK2219672T3 (en) 2007-11-09 2016-05-17 Peregrine Pharmaceuticals Inc The anti-VEGF antibody compositions and methods
UY31545A1 (es) 2007-12-20 2009-08-03 Nuevos derivados de 2-carboxamida cianoaminourea, sus sales y profarmacos farmacéuticamente aceptables, procesos de preparacion y aplicaciones
PT2279008T (pt) * 2008-04-18 2019-05-20 Angiochem Inc Composições farmacêuticas de paclitaxel, análogos de paclitaxel ou conjugados de paclitaxel e métodos relacionados de preparação e utilização
AU2009304560A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of GLP-1 agonists and uses thereof
JP5705118B2 (ja) 2008-10-15 2015-04-22 アンジオケム インコーポレーテッド 薬物送達のためのエトポシドおよびドキソルビシン複合体
US9914754B2 (en) * 2008-12-05 2018-03-13 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
AU2010239069B2 (en) 2009-04-20 2015-05-14 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an Angiopep-2 analog
JP5932642B2 (ja) 2009-07-02 2016-06-08 アンジオケム インコーポレーテッド 多量体ペプチドコンジュゲートおよびその使用
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
CN102762565A (zh) 2010-02-22 2012-10-31 弗·哈夫曼-拉罗切有限公司 吡啶并[3,2-d]嘧啶PI3δ抑制剂化合物及使用方法
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
AU2012213080B2 (en) 2011-01-31 2014-03-27 Novartis Ag Novel heterocyclic derivatives
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
PH12014500912A1 (en) 2011-10-28 2014-06-09 Novartis Ag Novel purine derivatives and their use in the treatment of disease
EP2788003A4 (en) * 2011-12-09 2015-05-27 Demerx Inc PHOSPHATESTER OF NORIBOGAIN
US10213432B2 (en) 2012-05-16 2019-02-26 Novartis Ag Dosage regimen for a PI-3 kinase inhibitor
WO2014098877A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
CA2930359C (en) 2013-12-06 2022-03-01 Novartis Ag Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
CN108472289A (zh) 2015-11-02 2018-08-31 诺华股份有限公司 磷脂酰肌醇3-激酶抑制剂的给药方案
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (OSRAM) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH481095A (de) * 1966-12-13 1969-11-15 Sandoz Ag Vefahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
HU202547B (en) 1991-03-28
GB8818462D0 (en) 1988-09-07
FR2622193B1 (fr) 1993-12-17
USRE35524E (en) 1997-06-03
NO883299L (no) 1989-02-24
US5041424A (en) 1991-08-20
FI883596A7 (fi) 1989-02-05
HK6392A (en) 1992-01-17
DK434088A (da) 1989-02-05
MY104321A (en) 1994-03-31
YU10490A (en) 1990-06-30
CY1625A (en) 1992-07-10
HU211960A9 (en) 1996-01-29
SK279325B6 (sk) 1998-10-07
IE61040B1 (en) 1994-09-07
NO920277L (no) 1989-02-24
NO920277D0 (no) 1992-01-22
SE502214C2 (sv) 1995-09-18
YU143688A (en) 1990-04-30
NO883299D0 (no) 1988-07-26
LU90138I2 (fr) 1997-11-26
US4904768A (en) 1990-02-27
IE882378L (en) 1989-02-04
NO172440C (no) 1993-07-21
AU2030688A (en) 1989-06-08
NL970042I2 (OSRAM) 2005-06-01
DK11992D0 (da) 1992-01-31
GR880100512A (en) 1989-05-25
HUT47303A (en) 1989-02-28
PT88186B (pt) 1995-07-03
DE3826562C2 (OSRAM) 1993-04-08
NO170284C (no) 1992-09-30
NO1998002I1 (no) 1998-01-14
IT8821535A0 (it) 1988-07-28
FR2622193A1 (fr) 1989-04-28
NL970042I1 (nl) 1998-03-02
DE3826562A1 (de) 1989-02-16
CN1061225A (zh) 1992-05-20
NO172440B (no) 1993-04-13
DK11992A (da) 1992-01-31
CZ541288A3 (cs) 1999-12-15
ATA195588A (de) 1994-07-15
CA1310637C (en) 1992-11-24
NL192683C (nl) 1997-12-02
PT88186A (pt) 1989-06-30
GR1000490B (el) 1992-07-30
IL87290A0 (en) 1989-01-31
SE8802815L (sv) 1989-02-05
MX173843B (es) 1994-03-30
LU87290A1 (fr) 1990-02-07
GB2207674A (en) 1989-02-08
DK169344B1 (da) 1994-10-10
HU905862D0 (en) 1991-03-28
IT1226825B (it) 1991-02-19
ES2010775A6 (es) 1989-12-01
JPH0699465B2 (ja) 1994-12-07
CN1027169C (zh) 1994-12-28
SK541288A3 (en) 1998-10-07
SE8802815D0 (sv) 1988-08-03
MX9202851A (es) 1992-06-30
DD274423A5 (de) 1989-12-20
BE1002982A4 (fr) 1991-10-15
NO920665L (no) 1989-02-24
NZ225615A (en) 1991-06-25
JPH01100188A (ja) 1989-04-18
IL87290A (en) 1993-01-31
DK434088D0 (da) 1988-08-03
KR890003790A (ko) 1989-04-18
NO170284B (no) 1992-06-22
NL192683B (OSRAM) 1997-08-01
FI883596A0 (fi) 1988-08-01
NO920665D0 (no) 1992-02-20
KR900006230B1 (ko) 1990-08-27
NL8801934A (nl) 1989-03-01
DD299067A5 (de) 1992-03-26
CZ286893B6 (cs) 2000-07-12
FI87790B (fi) 1992-11-13
YU10390A (en) 1990-06-30
CH676716A5 (OSRAM) 1991-02-28
AT398974B (de) 1995-02-27
AU610619B2 (en) 1991-05-23
SG101291G (en) 1992-01-17
HU208147B (en) 1993-08-30
GB2207674B (en) 1991-09-11

Similar Documents

Publication Publication Date Title
FI87790C (fi) Foerfarande foer framstaellning av epipodofyllotoxinglukosid-4'-fosfatderivat med antitumoer effekt
US4585762A (en) Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same
AU2007340371A1 (en) Cyclitols and their derivatives and their therapeutic applications
AU705248B2 (en) Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal product and their intended use in anticancer treatments
WO1984000367A1 (fr) Nouveaux derives de la glycerine pour la synthese de phospholipides
WO1998009668A2 (en) Use of amphiphiles as phosphatidyl choline synthesis inhibitors
CN109824725B (zh) 一种4-磷酸酯-2h-色烯衍生物的制备方法
HUP0300688A2 (hu) Bisz[N,N'-bisz(2-halogén-etil)-amino]-foszforamidát-származékok mint daganatellenes hatású hatóanyagok
EP0548834A1 (en) Stable hexahydrate of etoposide 4'-phosphate disodium salt
CA2325523A1 (en) Prodrugs of phosphorous-containing pharmaceuticals

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L74

Extension date: 20110412

FG Patent granted

Owner name: BRISTOL-MYERS SQUIBB COMPANY

MA Patent expired